cdmo.directory
← Compare landing

Alloy Therapeutics vs AXOlabs

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/alloytx/axolabs

CategoryAlloy TherapeuticsAXOlabs
Listed sitebothboth
SummaryProduct development organization offering AI/ML-driven antibody and multispecific discovery, TCR mimic (TCRm) discovery, and antisense oligonucleotide design, backed by transgenic mouse platforms and pharmacology studies.Integrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.
Services
  • Discovery Research
  • Protein Engineering
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • Bioinformatics & Data Science
  • High-Throughput Screening
  • Target Identification & Validation
  • Discovery Research
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • In Vitro Pharmacology
  • Oligonucleotide Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
Modalities
  • Biologics (Monoclonal Antibodies)
  • Oligonucleotide
  • Oligonucleotide
IndicationsData not yet provided.Data not yet provided.
LocationsData not yet provided.
  • Petaluma, Petaluma, California, USA
  • Berlin, Berlin, Berlin, Germany
  • Kulmbach, Kulmbach, Bavaria, Germany
CertificationsData not yet provided.
  • GLP · Identifier: Statement of GLP Compliance (06 Dec 2024)
  • GMP · Identifier: Certificate of GMP Compliance (Regierung von Oberfranken, 14 Oct 2024)
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.